stoxline Quote Chart Rank Option Currency Glossary
  
Inspire Medical Systems, Inc. (INSP)
136.81  -3.22 (-2.3%)    12-05 16:00
Open: 141.155
High: 142.26
Volume: 875,129
  
Pre. Close: 140.03
Low: 136.605
Market Cap: 4,048(M)
Technical analysis
2025-12-05 4:48:36 PM
Short term     
Mid term     
Targets 6-month :  166.51 1-year :  194.48
Resists First :  142.55 Second :  166.51
Pivot price 112.17
Supports First :  98.61 Second :  71.44
MAs MA(5) :  134.37 MA(20) :  105.93
MA(100) :  92.63 MA(250) :  0
MACD MACD :  14.7 Signal :  10.9
%K %D K(14,3) :  91.7 D(3) :  89
RSI RSI(14): 77.4
52-week High :  216 Low :  70.76
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ INSP ] has closed below upper band by 22.8%. Bollinger Bands are 223.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 8 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 142.37 - 143.09 143.09 - 143.55
Low: 134.92 - 135.85 135.85 - 136.45
Close: 135.47 - 136.88 136.88 - 137.78
Company Description

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Headline News

Sun, 07 Dec 2025
INSP DEADLINE: Faruqi & Faruqi Reminds Inspire Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026 - INSP - Newsfile

Sat, 06 Dec 2025
Inspire Medical Systems (INSP): Revisiting Valuation After Inspire V Launch Setbacks and Class Action Lawsuits - simplywall.st

Sat, 06 Dec 2025
Inspire Medical Systems (INSP) Price Target Increased by 12.39% to 128.11 - Nasdaq

Fri, 05 Dec 2025
Inspire Medical (INSP) Crashes Over 32%, "Inspire V" Launch Failure, Hagens Berman Urges Investors with Losses to Contact Firm by Jan. 5 - PR Newswire

Fri, 05 Dec 2025
Brown Capital Management LLC Has $47.68 Million Stake in Inspire Medical Systems, Inc. $INSP - MarketBeat

Fri, 05 Dec 2025
Inspire Medical Systems (INSP): Reassessing Valuation After a 65% One-Month Share Price Rebound - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 29 (M)
Shares Float 25 (M)
Held by Insiders 1.1 (%)
Held by Institutions 110.6 (%)
Shares Short 3,670 (K)
Shares Short P.Month 2,830 (K)
Stock Financials
EPS 1.46
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 22.94
Profit Margin 5 %
Operating Margin 4.3 %
Return on Assets (ttm) 2.8 %
Return on Equity (ttm) 6.5 %
Qtrly Rev. Growth 10.5 %
Gross Profit (p.s.) 25.79
Sales Per Share 30.37
EBITDA (p.s.) 1.69
Qtrly Earnings Growth -43.6 %
Operating Cash Flow 134 (M)
Levered Free Cash Flow 74 (M)
Stock Valuations
PE Ratio 93.7
PEG Ratio 0
Price to Book value 5.96
Price to Sales 4.5
Price to Cash Flow 29.73
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android